These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34508776)

  • 1. Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota, in Ulcerative Colitis.
    van de Guchte M; Mondot S; Doré J
    Gastroenterology; 2021 Dec; 161(6):1969-1981.e12. PubMed ID: 34508776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative stable states in the intestinal ecosystem: proof of concept in a rat model and a perspective of therapeutic implications.
    Van de Guchte M; Burz SD; Cadiou J; Wu J; Mondot S; Blottière HM; Doré J
    Microbiome; 2020 Nov; 8(1):153. PubMed ID: 33158453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.
    Shen ZH; Zhu CX; Quan YS; Yang ZY; Wu S; Luo WW; Tan B; Wang XY
    World J Gastroenterol; 2018 Jan; 24(1):5-14. PubMed ID: 29358877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
    Chen WX; Ren LH; Shi RH
    World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
    Kump PK; Gröchenig HP; Lackner S; Trajanoski S; Reicht G; Hoffmann KM; Deutschmann A; Wenzl HH; Petritsch W; Krejs GJ; Gorkiewicz G; Högenauer C
    Inflamm Bowel Dis; 2013 Sep; 19(10):2155-65. PubMed ID: 23899544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.
    Guo XY; Liu XJ; Hao JY
    J Dig Dis; 2020 Mar; 21(3):147-159. PubMed ID: 32040250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
    Hatton G; Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
    Ishikawa D; Sasaki T; Takahashi M; Kuwahara-Arai K; Haga K; Ito S; Okahara K; Nakajima A; Shibuya T; Osada T; Hiramatsu K; Watanabe S; Nagahara A
    Inflamm Bowel Dis; 2018 Nov; 24(12):2590-2598. PubMed ID: 30124831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Experimental Barrier Injury Triggers Ulcerative Colitis-Specific Innate Hyperresponsiveness and Ulcerative Colitis-Type Microbiome Changes in Humans.
    Seidelin JB; Bahl MI; Licht TR; Mead BE; Karp JM; Johansen JV; Riis LB; Galera MR; Woetmann A; Bjerrum JT
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1281-1296. PubMed ID: 34118489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota and ulcerative colitis.
    Ohkusa T; Koido S
    J Infect Chemother; 2015 Nov; 21(11):761-8. PubMed ID: 26346678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.
    Angriman I; Scarpa M; Castagliuolo I
    World J Gastroenterol; 2014 Aug; 20(29):9665-74. PubMed ID: 25110406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation for ulcerative colitis.
    Matsuoka K
    Immunol Med; 2021 Mar; 44(1):30-34. PubMed ID: 32663072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.
    Yan ZX; Gao XJ; Li T; Wei B; Wang PP; Yang Y; Yan R
    Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Ishikawa D; Sasaki T; Osada T; Kuwahara-Arai K; Haga K; Shibuya T; Hiramatsu K; Watanabe S
    Inflamm Bowel Dis; 2017 Jan; 23(1):116-125. PubMed ID: 27893543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study.
    Tian Y; Zhou Y; Huang S; Li J; Zhao K; Li X; Wen X; Li XA
    BMC Gastroenterol; 2019 Jul; 19(1):116. PubMed ID: 31272391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
    Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.